1. Andrews PA, Murphy MP, and Howell SB, 1985, Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res. 45:6250–3.
2. Andrews P, Velury S, Mann S, and Howell SB, 1988, Cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48:67–73.
3. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC and Ozols RF, 1987, Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47:414–8.
4. Bernal SD, Weinberg K, Kakefuda M, Stahel R, O’Hara C, and Wong YC, 1988, Membrane antigens of human bronchial epithelial cells. In Vitro 24:117–25.
5. Bernal SD, Speak JA, Boeheim K, Dreyfuss AI, Wright JE, Teicher BA, Rosowsky A, Tsao SW, and Wong YC, 1990, Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum. Mol Cell Biochem 95:61–70.